Immunotherapy and immunotherapy biomarkers for hepatocellular carcinoma
نویسندگان
چکیده
Hepatoma Research is an open access journal and focuses on all topics related to hepatoma. The following articles are especially welcome: pathogenesis, clinical examination early diagnosis of hepatoma, complications their preventions treatments, etc.
منابع مشابه
Immunotherapy of hepatocellular carcinoma
Current therapies for advanced hepatocellular carcinoma (HCC) are marginally effective and exacerbate underlying liver disease. The ability of immunotherapy to elicit nontoxic, systemic, long-lived anti-tumor activity makes it particularly well-suited for use in the setting of HCC. While therapeutic benefit has been achieved in early clinical trials, the efficacy of immune-based therapies is li...
متن کاملT Cell-Associated Immunotherapy for Hepatocellular Carcinoma.
Hepatocellular carcinoma (HCC) is one of the most common malignant diseases worldwide with limited therapeutic options. Accumulating evidences suggest that immunotherapy could be a promising option for treating HCC. T cell-associated immunotherapy lights up the hope for the improvement of complementary approach to conventional HCC treatments, which needs further research to consummate the clini...
متن کاملImmunotherapy for hepatocellular carcinoma following thermal ablation.
Hepatocellular carcinoma (HCC) is the fifth most common malignant disease and the third leading cause of cancer- associated deaths worldwide, and is characterized by a dismal prognosis. Despite the significant improvements achieved in liver transplantation, surgical resection, transcatheter arterial chemoembolization (TACE) and local ablative therapies such as percutaneous ethanol injection (PE...
متن کاملImmunotherapy for Hepatocellular Carcinoma: Current Status and Future Perspectives
For most patients with advanced hepatocellular carcinoma (HCC), surgery with curative intent or a locally ablative technique, such as percutaneous ethanol injection or radiofre‐ quency ablation, are no longer available [1]. Patients can now be treated using transarte‐ rial chemoembolization (TACE) or systemic chemotherapy. Several chemotherapeutic drugs have been developed and tested. The anti-...
متن کاملAlpha-fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma.
The majority of human hepatocellular carcinomas overexpress alpha-fetoprotein (AFP). Two genetic immunization strategies were used to determine whether AFP could serve as a target for T-cell immune responses. Dendritic cells engineered to express AFP produced potent T-cell responses in mice, as evidenced by the generation of AFP-specific CTLs, cytokine-producing T cells, and protective immunity...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Hepatoma research
سال: 2021
ISSN: ['2394-5079', '2454-2520']
DOI: https://doi.org/10.20517/2394-5079.2020.118